A study led by scientists at NYU Langone Health sheds light on how the major cancer gene BRCA2 determines which cancer cells can be killed by a class of precision cancer drugs called PARP inhibitors.
Local residents rest in a mosquito net while the emergency light beside lights up the dark night in Mandalay, Myanmar, April ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback